Another Dimension: How 3D Organoids Are Transforming Cancer Immunotherapy
On-Demand Webinar
Duration: 54 minutes
Overview
Immunotherapy in oncology has become a pivotal strategy in the eradication of cancer, utilizing the body's own immune defenses to target and destroy malignant cells. The path to developing effective immunotherapies, however, is fraught with intricate challenges, including the inadequacies of conventional cell models that overlook critical biological details.
The advent of organoids, compact three-dimensional constructs that accurately represent the cellular milieu of actual human tissues, is proving to be a critical asset in this research field.
Watch the Science Webinar on-demand to:
- Gain insights into the transition by immuno-oncology researchers from traditional cell cultures to dynamic 3D cell models
- Understand the challenges associated with adopting organoid technology and strategies for successful implementation
- Learn about the advancements that 3D organoids are bringing to the realm of immunotherapeutic cancer treatments
Webinar Speaker
Xiaowei Xu, M.D., Ph.D.
University of Pennsylvania
Philadelphia, PA
Dr. Xiaowei Xu is a professor of pathology and laboratory medicine at the Hospital of the University of Pennsylvania and a professor of dermatology at the University of Pennsylvania Perelman School of Medicine. His research involves developing cellular and extracellular vesicle-based immunotherapies for melanoma and other skin cancers. Dr. Xu’s lab is dedicated to studying melanocytes and melanoma biology with the aim of developing effective therapies for vitiligo, melasma, melanoma, and other skin conditions.
